123 related articles for article (PubMed ID: 2007926)
1. Partial reversibility of cisplatin nephrotoxicity in children.
Brock PR; Koliouskas DE; Barratt TM; Yeomans E; Pritchard J
J Pediatr; 1991 Apr; 118(4 Pt 1):531-4. PubMed ID: 2007926
[TBL] [Abstract][Full Text] [Related]
2. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin dose rate as a risk factor for nephrotoxicity in children.
Skinner R; Pearson AD; English MW; Price L; Wyllie RA; Coulthard MG; Craft AW
Br J Cancer; 1998 May; 77(10):1677-82. PubMed ID: 9635848
[TBL] [Abstract][Full Text] [Related]
4. Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin.
Jones DP; Chesney RW
Curr Opin Pediatr; 1995 Apr; 7(2):208-13. PubMed ID: 7787938
[TBL] [Abstract][Full Text] [Related]
5. The long-term effect of cisplatin on renal function.
Fjeldborg P; Sørensen J; Helkjaer PE
Cancer; 1986 Nov; 58(10):2214-7. PubMed ID: 3756770
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis.
Ariceta G; Rodriguez-Soriano J; Vallo A; Navajas A
Med Pediatr Oncol; 1997 Jan; 28(1):35-40. PubMed ID: 8950334
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
9. The effect of cisplatin on renal function in patients with testicular tumours.
MacLeod PM; Tyrell CJ; Keeling DH
Clin Radiol; 1988 Mar; 39(2):190-2. PubMed ID: 3128418
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer.
Hansen SW; Groth S; Daugaard G; Rossing N; Rørth M
J Clin Oncol; 1988 Nov; 6(11):1728-31. PubMed ID: 2460594
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.
Skinner R; Cotterill SJ; Stevens MC
Br J Cancer; 2000 May; 82(10):1636-45. PubMed ID: 10817497
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin ototoxicity in children: a practical grading system.
Brock PR; Bellman SC; Yeomans EC; Pinkerton CR; Pritchard J
Med Pediatr Oncol; 1991; 19(4):295-300. PubMed ID: 2056973
[TBL] [Abstract][Full Text] [Related]
13. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
14. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose.
Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
Pediatr Blood Cancer; 2010 Jul; 54(7):983-9. PubMed ID: 20405516
[TBL] [Abstract][Full Text] [Related]
15. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment.
Pietilä S; Ala-Houhala M; Lenko HL; Harmoinen AP; Turjanmaa V; Mäkipernaa A
Pediatr Blood Cancer; 2005 Apr; 44(4):363-9. PubMed ID: 15586356
[TBL] [Abstract][Full Text] [Related]
16. Renal toxicity of cisplatin in children.
Womer RB; Pritchard J; Barratt TM
J Pediatr; 1985 Apr; 106(4):659-63. PubMed ID: 2984399
[TBL] [Abstract][Full Text] [Related]
17. Long-term renal effect of cisplatin in man.
Brillet G; Deray G; Jacquiaud C; Mignot L; Bunker D; Meillet D; Raymond F; Jacobs C
Am J Nephrol; 1994; 14(2):81-4. PubMed ID: 8080010
[TBL] [Abstract][Full Text] [Related]
18. Persisting renotubular sequelae after cisplatin in children and adolescents.
Bianchetti MG; Kanaka C; Ridolfi-Lüthy A; Hirt A; Wagner HP; Oetliker OH
Am J Nephrol; 1991; 11(2):127-30. PubMed ID: 1951473
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin nephrotoxicity: experimental and clinical studies.
Daugaard G
Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
[TBL] [Abstract][Full Text] [Related]
20. Progressive glomerular toxicity of ifosfamide in children.
Prasad VK; Lewis IJ; Aparicio SR; Heney D; Hale JP; Bailey CC; Kinsey SE
Med Pediatr Oncol; 1996 Sep; 27(3):149-55. PubMed ID: 8699991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
